Prognostic stratification based on m(5)C regulators acts as a novel biomarker for immunotherapy in hepatocellular carcinoma

BACKGROUND: Immunotherapy is a promising anti-cancer strategy in hepatocellular carcinoma (HCC). However, a limited number of patients can benefit from it. There are currently no reliable biomarkers available to find the potential beneficiaries. Methylcytosine (m(5)C) is crucial in HCC, but its role...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ping, Zhu, Ziqing, Ma, Jiayao, Wei, Le, Han, Ying, Shen, Edward, Tan, Xiao, Chen, Yihong, Cai, Changjing, Guo, Cao, Peng, Yinghui, Gao, Yan, Liu, Yongting, Huang, Qiaoqiao, Gao, Le, Li, Yin, Jiang, Zhaohui, Wu, Wantao, Liu, Yihan, Zeng, Shan, Li, Wei, Feng, Ziyang, Shen, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505913/
https://www.ncbi.nlm.nih.gov/pubmed/36159831
http://dx.doi.org/10.3389/fimmu.2022.951529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505913/
https://www.ncbi.nlm.nih.gov/pubmed/36159831
http://dx.doi.org/10.3389/fimmu.2022.951529

Ejemplares similares